Clinical & Translational Science

The Urologic Clinical and Translational Science (UCATS) program encompasses all studies involving patients or populations conducted by or in collaboration with our department. Current research efforts are focused on urologic malignancies, but is expanding to include those with benign urologic diseases and conditions. This program provides necessary oversight and infrastructure for study prioritization and implementation to faculty research and collaborations. The Program Director, June Chan, ScD, facilitates the implementation and execution of research projects, assists in setting research priorities; develops new collaborations; and establishes goals and budgets for the overall program. The Co-Director, Matthew Cooperberg, MD, MPH, brings clinical expertise and additional scientific leadership to the program. For descriptions of the UCATS Program's research see links on the left side of this page.